ReShape Lifesciences reports Q1 results
Seeking Alpha News (Wed, 15-May 5:02 PM ET)
Globe Newswire (Wed, 15-May 4:05 PM ET)
Globe Newswire (Tue, 14-May 8:31 AM ET)
Globe Newswire (Mon, 1-Apr 4:05 PM ET)
Globe Newswire (Thu, 28-Mar 8:31 AM ET)
Globe Newswire (Mon, 4-Mar 8:31 AM ET)
ReShape Lifesciences Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 FLEX
Globe Newswire (Thu, 22-Feb 8:31 AM ET)
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Reshape Lifesciences trades on the NASDAQ stock market under the symbol RSLS.
As of May 17, 2024, RSLS stock price climbed to $0.18 with 5,728,938 million shares trading.
RSLS has a beta of 2.20, meaning it tends to be more sensitive to market movements. RSLS has a correlation of 0.09 to the broad based SPY ETF.
RSLS has a market cap of $4.13 million. This is considered a Sub-Micro Cap stock.
Last quarter Reshape Lifesciences reported $2 million in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-156,000 and exceeded earnings estimates by $.07.
The top ETF exchange traded funds that RSLS belongs to (by Net Assets): VXF.
RSLS has underperformed the market in the last year with a return of -93.1%, while the SPY ETF gained +29.1%. In the last 3 month period, RSLS fell short of the market, returning +1.4%, while SPY returned +6.3%. However, in the most recent 2 weeks RSLS has outperformed the stock market by returning +4.1%, while SPY returned +3.6%.
RSLS support price is $.16 and resistance is $.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RSLS stock will trade within this expected range on the day.